Concepedia

Sarah Robertson

SR

37

Publications

4.5K

Citations

25

H-Index

1989

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

University of Tennessee at Knoxville

United States Food and Drug Administration

Center for Drug Evaluation and Research

National Institutes of Health

Sarah Robertson is an author at Vertex Pharmaceuticals (United States) specializing in medicine, psychology, and psychiatry.

ORCID

Top concepts

Publications per year

1989–2020

37

Publications

37

Autism diagnostic interview: A standardized investigator-based instrument

Ann Le Couteur, Michael Rutter, Catherine Lord et al. · Journal of Autism and Developmental Disorders · 1989 · 1K citations

, , +3

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

D. Keating, Gautham Marigowda, Lucy Burr et al. · New England Journal of Medicine · 2018 · 707 citations · Full text

A Broader Phenotype of Autism: The Clinical Spectrum in Twins

Ann Le Couteur, Anthony Bailey, Susan Goode et al. · Journal of Child Psychology and Psychiatry · 1996 · 447 citations

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

Jane C. Davies, Steve Cunningham, William T. Harris et al. · The Lancet Respiratory Medicine · 2016 · 339 citations · Full text

, , +2

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

Jane C. Davies, Samuel M. Moskowitz, Cynthia D. Brown et al. · New England Journal of Medicine · 2018 · 320 citations · Full text

Rows per page

1–5 of 37